| News

BaseLaunch is top European accelerator

21.05.2019

Healthcare Accelerator BaseLaunch, which is operated by the location promotion organization BaselArea.swiss, is among the leading accelerators of its kind in Europe, according to a media report. BaseLaunch is the only Swiss Healthcare Accelerator to feature.

BaseLaunch

“Sifted”, an online magazine supported by the “Financial Times”, has analyzed the leading Healthcare Accelerators in Europe. It aimed to find out which accelerators provide healthcare startups with the best opportunities for development and to find investment.

The list of the best European accelerators that specialize in healthcare is very short, with “Sifted” naming just eleven institutions. BaseLaunch, which is operated by BaselArea.swiss, is the only Swiss institution to feature. According to the article, BaseLaunch is the rarest type of accelerator – it provides investment and support without asking for equity in return. Instead, big industry funding comes from companies like NovartisRocheRoivant SciencesJohnson & JohnsonPfizer and KPMG.

Basel is already world-famous in life sciences, but BaseLaunch is supporting even more startups making exciting developments. It offers them business development and legal services, as well as fully equipped labs. Furthermore, grants are available up to 250,000 Swiss francs per company by the end of the 15-month programme. BaseLaunch looks for companies innovating in the therapeutics space, medtech and diagnostics.

In Germany, the only country in which “Sifted” names several high-ranking healthcare accelerators, there are three institutions listed. Like Switzerland, the other countries featured – Great Britain, Sweden, the Netherlands, Spain, Italy, Denmark and Hungary – have only one accelerator included in the ranking.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area – exactly the right chemistry for South Korean pharma companies
Basel Area Business & Innovation, Innovation, Invest

Basel Area – exactly the right chemistry for South Korean pharma companies

KPBMA and Basel Area Business & Innovation establish tailored collaboration to support Korean biopharmaceutical companies to enter the European market

Read More
Basel Area supporting three digital health startups
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Basel Area supporting three digital health startups

Basel Area Business & Innovation will be offering intensive support to the three winners of its DayOne Digital Health Accelerator...

Read More
Gray establishes presence in Basel
Basel Area Business & Innovation, Innovation, Invest

Gray establishes presence in Basel

The North American fully integrated specialty service provider Gray has established a subsidiary in Basel. The key factors in favor...

Read More
Artificial Intelligence able to identify potentially life-saving antibiotics
Basel Area Business & Innovation, Innovation, Invest

Artificial Intelligence able to identify potentially life-saving antibiotics

A computer algorithm has identified antibiotics that that are still effective against infections in which multi-resistant germs are present. University...

Read More
Investors give Anaveon 110 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

Investors give Anaveon 110 million Swiss francs

Anaveon has received investment commitments amounting to 110 million Swiss francs in a Serie B funding round. The Basel-based biopharmaceutical...

Read More
Basel alliance seeks to combat antibiotic resistance
Basel Area Business & Innovation, Innovation, Invest

Basel alliance seeks to combat antibiotic resistance

The Spearhead alliance has been founded in Basel with the aim of combating the silent pandemic of antimicrobial resistance. By...

Read More
Kinarus and Noorik awarded federal grants
Basel Area Business & Innovation, Innovation, Invest

Kinarus and Noorik awarded federal grants

The Basel-based biopharmaceutical companies Kinarus and Noorik have been awarded federal grants for their clinical trials investigating drug candidates to...

Read More
Alloy acquires deepCDR and will expand Basel site
Basel Area Business & Innovation, Innovation, Invest

Alloy acquires deepCDR and will expand Basel site

Alloy Therapeutics, a biotechnology firm from Boston in the USA, has acquired the Basel-based startup deepCDR Biologics. Alloy labs and...

Read More
Basel Healthtech fund successfully closed
Basel Area Business & Innovation, Innovation, Invest

Basel Healthtech fund successfully closed

The venture capital firm MTIP has announced the successful closing of its FUND II. It is one of the first...

Read More
Roche tests able to detect Omicron
Basel Area Business & Innovation, Innovation, Invest

Roche tests able to detect Omicron

The Roche subsidiary TIB Molbiol has developed new coronavirus testing kits that can also detect the new Omicron variant of...

Read More
1 2 3 31

Do you have a question? We'd like to hear from you.